Evidence map›Paper›PMID 40177489›Full record

ArticleFrontiers in microbiology2025

Seven-year change of prevalence, clinical risk factors, and mortality of patients with carbapenem-resistant

Haifang Kong, Yong Liu, Ling Yang, Qianqian Chen, Yanchun Li, Zhidong Hu, Xuequan Feng, Yamin Chai, Zuoliang Dong

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Determinants of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Molecular Insights into Carbapenem Resistance inInternational journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. FromFrontiers in medicine · 2025
    Article
  7. Article
  8. Clinical characteristics, risk factors and prognosis ofFrontiers in cellular and infection microbiology · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haifang KongDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Yong LiuTianjin First Central Hospital of Nankai University, Tianjin, China.
Ling YangDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Qianqian ChenDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Yanchun LiDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Zhidong HuDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Xuequan FengTianjin First Central Hospital of Nankai University, Tianjin, China.
Yamin ChaiDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Zuoliang DongDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

bloodstream infectioncarbapenem resistancecase-case-control studyKlebsiella pneumoniaerisk factors

Identifiers

PMID40177489
PMCPMC11962001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.